Recently, a delegation from Gnosis by Lesaffre, a globally renowned biotechnology company, visited Unisons for an in-depth tour and strategic exchange. The two sides engaged in comprehensive discussions on cutting-edge industry technologies, product innovation, and future cooperation opportunities.
This visit not only strengthened mutual understanding between the two companies but also injected new momentum into international collaboration and the high-quality development of the probiotics industry.
During the visit, Unisons’s Chairman and R&D leadership team accompanied the Gnosis by Lesaffre delegation throughout their tour of the Probiotics Smart Exhibition Hall, the High-Tech Probiotics Research Institute, and the pharmaceutical-grade intelligent manufacturing facilities.
Representatives from Gnosis by Lesaffre Global Headquarters, including Mr. Jerome Caussin and Mr. Giorgio Grimaldi, expressed strong recognition of Unisons’s high-standard production environment, advanced strain manufacturing processes, and ongoing research into next-generation probiotics.
At the intelligent probiotic packaging line, the Gnosis by Lesaffre team showed particular interest in the technical details related to live probiotic strain stability protection. They highly appreciated Unisons’s rigorous manufacturing processes and quality control standards in large-scale commercial production.
Following the facility tour, both parties held a high-level strategic discussion. The two teams exchanged in-depth views on global biotechnology trends, solutions to industry challenges, and potential areas for future collaboration.
Representatives from Gnosis by Lesaffre commented that Unisons’s strong capabilities in R&D innovation and intelligent manufacturing demonstrated remarkable efficiency and professionalism. They expressed expectations for further cooperation and deeper exchanges across multiple dimensions in the future.
Unisons also highlighted that, as a global industry leader, Lesaffre’s extensive experience and international perspective provide valuable insights for the development of the probiotics sector. The company hopes to use this exchange as an opportunity to jointly explore new possibilities in biotechnology and functional health solutions.
Gnosis by Lesaffre is part of the Lesaffre Group, a French company with more than 170 years of history. It is among the few global biotechnology companies that have established a complete value chain spanning from strain discovery and screening to clinical nutrition intervention.
As a leading enterprise in China’s intelligent probiotics manufacturing sector, Unisons remains committed to developing world-class microbiome-based ingredients with exceptional quality and reliability.
This in-depth exchange not only enhanced the global industry leaders’ understanding of China’s advanced probiotics manufacturing capabilities but also laid a solid foundation for future cooperation in areas such as global ingredient supply chains, innovative functional food development, and microbiome health solutions.
Driven by openness and powered by collaboration, Unisons will continue to uphold its vision of “becoming a global supplier of high-quality probiotics.” Through dialogue and cooperation with world-class partners, Unisons will continue to embrace global innovation and contribute to advancing human microbiome health.
